Cheyne Capital Management (UK)’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Cheyne Capital Management (UK)’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$85K	–	38
2018 Q3	$85K	Hold	50,000	–	–	0.05%	41
2018 Q2	$87K	Hold	50,000	–	–	0.06%	34
2018 Q1	$91K	Sell	50,000 -156,500	-76%	-$331K	0.04%	34
2017 Q4	$462K	Sell	206,500 -445,000	-68%	-$1.11M	0.2%	33
2017 Q3	$1.88M	Buy	651,500 +511,500	+365%	+$1.74M	0.68%	28
2017 Q2	$622K	Hold	140,000	–	–	0.24%	37
2017 Q1	$652K	Buy	140,000 +87,500	+167%	+$507K	0.25%	26
2016 Q4	$320K	Buy	+52,500	New	+$274K	0.18%	24
2016 Q3	–	Sell	-66,000	Closed	-$250K	–	36
2016 Q2	$250K	Buy	+66,000	New	+$224K	0.2%	23
2015 Q3	–	Sell	-50,000	Closed	-$414K	–	85
2015 Q2	$414K	Buy	+50,000	New	+$242K	0.13%	75

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Cheyne Capital Management (UK)'s SGYP Position: Q4 2018 in Review

Cheyne Capital Management (UK) sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 50,000 shares — an estimated $85K sold.

Cheyne Capital Management (UK) first reported a position in SGYP in Q2 2015 and held it in 10 quarters. The position peaked at $1.88M in Q3 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Cheyne Capital Management (UK) reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Cheyne Capital Management (UK) sold 50,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $85K.
Cheyne Capital Management (UK) first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 10 quarters.
Cheyne Capital Management (UK)'s Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.88M in Q3 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2018, filed 5 Feb 2019.